Frontiers in Pharmacology (Dec 2022)
Editorial: Model-informed drug development and evidence-based translational pharmacology
- Jinxin Zhao,
- Xiao Zhu,
- Songwen Tan,
- Chuanpin Chen,
- Amal Kaddoumi,
- Xiu-Li Guo,
- Yu-Wei Lin,
- Yu-Wei Lin,
- Yu-Wei Lin,
- Yu-Wei Lin,
- S. Y. Amy Cheung
Affiliations
- Jinxin Zhao
- Biomedicine Discovery Institute, Infection and Immunity Program and Department of Microbiology, Monash University, Melbourne, VIC, Australia
- Xiao Zhu
- Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China
- Songwen Tan
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
- Chuanpin Chen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
- Amal Kaddoumi
- Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States
- Xiu-Li Guo
- Department of Pharmacology, School of Pharmaceutical Science, Shandong University, Jinan, China
- Yu-Wei Lin
- Biomedicine Discovery Institute, Infection and Immunity Program and Department of Microbiology, Monash University, Melbourne, VIC, Australia
- Yu-Wei Lin
- Malaya Translational and Clinical Pharmacometrics Group, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia
- Yu-Wei Lin
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia
- Yu-Wei Lin
- Integrated Drug Development, Certara, NJ, United States
- S. Y. Amy Cheung
- Integrated Drug Development, Certara, NJ, United States
- DOI
- https://doi.org/10.3389/fphar.2022.1086551
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- model informed drug development
- pharmacometrics
- artificial intelligence
- machine learing
- translational pharmacology